Annexon, Inc.
ANNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001528115
In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $99.8K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 216
- 13F valueReported value at the end of Q2 2026
- $1.02B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ANNX, Q2 2026
No superinvestor reported holding ANNX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Annexon, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2026 (view filing)4:15 PM ET | Sep 24 | 1 day | Love DouglasPRESIDENT AND CEO | PPurchase | +26.1K | $3.83 | +$99.8K | +7.2%390.5K after | |
| May 29, 2026 (view filing) | May 28 | 1 day | Satter Muneer ADirector | PPurchase | +613.5K | $5.41 | +$3.32M | +6.3%10.3M after | |
| May 13, 2026 (view filing) | May 11 | 2 days | Carson William H.Director | PPurchase | +8.00K | $5.78 | +$46.2K | +11.4%78.4K after | 10b5-1 |
| Apr 14, 2026 (view filing) | Apr 10 | 4 days | Carson William H.Director | PPurchase | +8.00K | $6.20 | +$49.6K | +12.8%70.4K after | 10b5-1 |
| Mar 12, 2026 (view filing) | Mar 10 | 2 days | Carson William H.Director | PPurchase | +8.00K | $5.67 | +$45.4K | +14.7%62.4K after | 10b5-1 |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER | SSale | −5.89K | $5.43 | −$32.0K | −3.2%180.1K after | |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Yednock TedEVP & CHIEF INNOVATION OFFICER | SSale | −5.57K | $5.42 | −$30.2K | −3.5%154.2K after | |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Overdorf MichaelEVP & CHIEF BUSINESS OFFICER | SSale | −4.34K | $5.42 | −$23.5K | −2.3%182.6K after | |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Dananberg JamieCHIEF MEDICAL OFFICER | SSale | −5.82K | $5.43 | −$31.6K | −4.5%123.6K after | |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Lew JenniferEVP & CHIEF FINANCIAL OFFICER | SSale | −5.57K | $5.42 | −$30.2K | −3.2%170.7K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Annexon, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 19,518,496 | $111.5M | 0.00% | +8,882,848+83.5% | Added |
| BlackRock, Inc. | 13,539,744 | $77.3M | 0.00% | +2,601,235+23.8% | Added |
| Redmile Group, LLC | 11,869,877 | $67.8M | 4.55% | −2,679,891−18.4% | Reduced |
| State Street Corp | 9,824,321 | $56.1M | 0.00% | +2,905,066+42.0% | Added |
| BVF Inc | 8,698,173 | $49.7M | 1.27% | 00.0% | Unchanged |
| Woodline Partners LP | 6,925,067 | $39.5M | 0.12% | +4,587,930+196.3% | Added |
| Vanguard Capital Management LLC | 6,871,015 | $39.2M | 0.00% | +914,426+15.4% | Added |
| Mak Capital One LLC | 5,862,180 | $33.5M | 4.69% | +1,138,137+24.1% | Added |
| Goldman Sachs Group Inc | 5,825,579 | $33.3M | 0.00% | +3,672,699+170.6% | Added |
| Siren, L.L.C. | 4,458,646 | $25.5M | 0.52% | +500,000+12.6% | Added |